All Stories

  1. TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells

    Article • Journal of Molecular Medicine, August 2024, Springer Science + Business Media

    Annamaria Piscazzi

  2. Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer

    Article • The Oncologist, May 2023, Oxford University Press (OUP)

    Annamaria Piscazzi

  3. TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation

    Article • International Journal of Oncology, May 2022, Spandidos Publications

    Annamaria Piscazzi

  4. Differential and divergent activity of insulin‑like growth factor binding protein 6 in platinum‑sensitive versus platinum‑resistant high‑grade serous ovarian carcinoma cell lines

    Article • Oncology Letters, April 2022, Spandidos Publications

    Annamaria Piscazzi

  5. Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era

    Article • International Journal of Molecular Sciences, July 2021, MDPI AG

    Annamaria Piscazzi

  6. Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma

    Article • Journal of Oncology, April 2021, Hindawi Publishing Corporation

    Annamaria Piscazzi

  7. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells

    Article • Tumor Biology, March 2018, SAGE Publications

    Annamaria Piscazzi

  8. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination

    Article • The Journal of Pathology, August 2017, Wiley

    Annamaria Piscazzi

  9. DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment

    Article • PLoS ONE, December 2016, PLOS

    Annamaria Piscazzi

  10. TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells

    Article • Endocrine Related Cancer, July 2016, Bioscientifica

    Annamaria Piscazzi

  11. RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study

    Article • Oncology Letters, June 2015, Spandidos Publications

    Annamaria Piscazzi

  12. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma

    Article • Oncotarget, June 2015, Impact Journals, LLC

    Annamaria Piscazzi

  13. The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers

    Article • Thyroid, March 2014, Mary Ann Liebert Inc

    Professor Daniela Pasquali, Prof Lorenzo Lo Muzio, Annamaria Piscazzi

  14. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1

    Article • Molecular Oncology, May 2013, Wiley

    Annamaria Piscazzi

  15. Activation of the RAS/RAF/ERK Signaling Pathway Contributes to Resistance to Sunitinib in Thyroid Carcinoma Cell Lines

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2012, Endocrine Society

    Annamaria Piscazzi

  16. Epidermal Growth Factor Receptor 1 Expression Is Upregulated in Undifferentiated Thyroid Carcinomas in Humans

    Article • Thyroid, November 2011, Mary Ann Liebert Inc

    Annamaria Piscazzi

  17. Heat shock proteins, cell survival and drug resistance: The mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy

    Article • Gynecologic Oncology, May 2010, Elsevier

    Annamaria Piscazzi

  18. S100A13 is a new angiogenic marker in human melanoma

    Article • Modern Pathology, March 2010, Nature

    Annamaria Piscazzi

  19. Novel Strategies to Improve the Efficacy of Anticancer Agents in Human Colorectal Carcinoma

    Article • European Oncology & Haematology, January 2010, Touch Digital Media, Ltd.

    Annamaria Piscazzi

  20. TRAP1 and SORCIN cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC)

    Article • BMC Proceedings, January 2010, Springer Science + Business Media

    Annamaria Piscazzi

  21. Targeting Epidermal Growth Factor Receptor 1 Signaling in Human Thyroid-Stimulating Hormone–Independent Thyroid Carcinoma FRO Cells Results in a More Chemosensitive and Less Angiogenic Phenotype

    Article • Thyroid, June 2009, Mary Ann Liebert Inc

    Annamaria Piscazzi

  22. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells

    Article • Cancer Letters, June 2009, Elsevier

    Annamaria Piscazzi

  23. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo

    Article • The Prostate, May 2009, Wiley

    Annamaria Piscazzi

  24. Nevirapine Toxicity in Non-HIV Cancer Patients

    Article • Chemotherapy, January 2008, Karger Publishers

    Annamaria Piscazzi

  25. Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma

    Article • International Journal of Cancer, January 2008, Wiley

    Annamaria Piscazzi

  26. Reverse Transcriptase Inhibitors Down-Regulate Cell Proliferationin Vitroandin Vivoand Restore Thyrotropin Signaling and Iodine Uptake in Human Thyroid Anaplastic Carcinoma

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2005, Endocrine Society

    Dr Corrado Spadafora, Annamaria Piscazzi